The American Society for Pharmacology and Experimental Therapeutics, a FASEB member society, will end page charges for new submissions from all authors who opt-in for Open Access.
The American Association of Immunologists announces the appointment of Loretta Doan, PhD, as its new Chief Executive Officer.
The Journal of Pharmacology and Experimental Therapeutics (JPET) is launching a one-year Editorial Fellowship Program.
The American Association of Immunologists, a FASEB member society, supports scientists’ career development by providing travel awards to those interested in traveling to learn techniques needed for their research.
FASEB joins the ORCID US Community, a consortium of nonprofit institutions working to advance open science and research integrity.
The American Association of Immunologists, a FASEB member society, supports the career development of young scientists by providing eligible principal investigators with one year of salary support for a trainee in their labs.
FASEB is now accepting nominations for its 2023 Excellence in Science Awards.
FASEB joins alliance of organizations to identify, articulate, and advance open science, open data, and open scholarship norms and practices within their disciplines.
FASEB Excellence in Science Awards showcase outstanding achievements of women in the biological and biomedical sciences.
Can’t resist your pup’s adoring expression when he begs for a treat? A new study reveals key anatomical features that could explain what makes dogs’ faces so appealing. The findings also suggest that humans contributed to dogs’ ability to form facial expressions through thousands of years of selective breeding.
Findings from a new study are providing important insights into the spread of Rocky Mountain spotted fever, which is transmitted from dogs to people through ticks. The new data are being used to create models that could help predict, and possibly prevent, future outbreaks.
Results from a new study suggest that two sugar substitutes disrupt the function of a protein that plays a vital role in liver detoxification and the metabolism of certain drugs. These sugar substitutes, also known as non-nutritive sweeteners, provide a sweet taste with few or no calories.
In a new study conducted in rats, scientists report evidence that vitamin K could help protect against aging-related cognitive declines associated with Alzheimer’s disease and other forms of dementia.
In a new study, many athletes reported symptoms that are often used to diagnose concussions even though they did not suffer a head injury. The findings suggest that some symptoms, such as fatigue and neck pain, could be attributed to intense exercise rather than a brain injury.
Almost half of the U.S. adult population has high blood pressure — or hypertension — and about 20% of these patients have treatment-resistant hypertension. The reason why some people are resistant to treatment has been a mystery, but new study results show that a certain gut bacterium may be an important factor.
A new study using prenatal brain scans revealed significant differences in brain structures at around 25 weeks’ gestation between children who were later diagnosed with ASD and those who were not. The study adds to mounting evidence that autism begins in early development and suggests possible opportunities to identify the disorder at an earlier age.
Researchers have identified a family of proteins that is significantly elevated in the saliva of patients hospitalized with COVID-19. The proteins, known as ephrin ligands, could potentially serve as a biomarker to help doctors identify patients who are at risk for serious illness.
A simple blood test for women of all ages and risk levels could one day be possible thanks to a new set of protein biomarkers that researchers identified using breast milk.
A study conducted in rats suggests that taking vitamin C may help to counteract the muscle atrophy that is a common side effect of the chemotherapy drug doxorubicin. Although clinical studies would be needed to determine the safety and effectiveness of taking vitamin C during doxorubicin treatment, the findings suggest vitamin C may represent a promising opportunity to reduce some of the drug’s most debilitating side effects.
Findings from a new animal study suggest that cannabidiol (CBD) and tetrahydrocannabinol (THC) might be safe for use with opioid pain relievers. Although more studies are needed, the results suggest that these compounds might be a low-risk way to reduce the dose of opioids needed to relieve pain.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right